Expanded Access for ATB200/AT2221 for the Treatment of IOPD

NCT04327973 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Pompe Disease Infantile-Onset

Interventions

BIOLOGICAL: ATB200
DRUG: AT2221

Sponsor

Amicus Therapeutics